Advanced

The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visceral fat

Jendle, J.; Nauck, M. A.; Matthews, D.; Frid, Anders LU ; Hermansen, K.; During, M.; Zdravkovic, M.; Strauss, B. and Garber, A. (2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.318-318
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Diabetologia
volume
51
issue
S1
pages
318 - 318
publisher
Springer Verlag
conference name
44th EASD Annual Meeting of the European Association for the Study of Diabetes
external identifiers
  • wos:000258660201087
ISSN
1432-0428
DOI
10.1007/s00125-008-1117-6
language
English
LU publication?
yes
id
94e04cce-8382-4c42-b6e4-eb998f7f7a4f (old id 1249608)
date added to LUP
2008-11-07 09:17:20
date last changed
2016-04-19 15:24:22
@misc{94e04cce-8382-4c42-b6e4-eb998f7f7a4f,
  author       = {Jendle, J. and Nauck, M. A. and Matthews, D. and Frid, Anders and Hermansen, K. and During, M. and Zdravkovic, M. and Strauss, B. and Garber, A.},
  issn         = {1432-0428},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {S1},
  pages        = {318--318},
  publisher    = {Springer Verlag},
  series       = {Diabetologia},
  title        = {The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visceral fat},
  url          = {http://dx.doi.org/10.1007/s00125-008-1117-6},
  volume       = {51},
  year         = {2008},
}